CN103330867B - Preparation method of powder for treating senile vaginitis - Google Patents
Preparation method of powder for treating senile vaginitis Download PDFInfo
- Publication number
- CN103330867B CN103330867B CN201310268846.9A CN201310268846A CN103330867B CN 103330867 B CN103330867 B CN 103330867B CN 201310268846 A CN201310268846 A CN 201310268846A CN 103330867 B CN103330867 B CN 103330867B
- Authority
- CN
- China
- Prior art keywords
- parts
- powder
- preparation
- reduced pressure
- dry extract
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Abstract
The invention discloses a preparation method of powder for treating senile vaginitis to solve the problem of treatment of senile vaginitis. The preparation method is characterized by comprising the steps of (1) distilling coarse powder of barks of pittosporum tobira, root of fortune apios and radix ephedrae at reduced pressure to extract volatile oil; (2) decocting tetrapanax papyriferum at reduced pressure to obtain filtrate; (3) decocting trikeraia hookeri, magnolia amoena, Chinese taxillus herb, coking malt, coking medicated leaven, leaf of mimoselike rosewood, peach gum, cassia twig and the dregs obtained in the step 1 with water to obtain filtrate for standby use; (4) combining the filtrates obtained in the steps 2 and 3, concentrating the filtrate mixture into dry extract at reduced pressure and grinding the dry extract to obtain dry extract powder; and (5) spraying the volatile oil obtained in the step 1 into the dry extract powder obtained in the step 4, mixing the materials uniformly, sieving the mixture with a 100-mesh sieve and subpackaging the powder, thus preparing the powder. Clinical experiments prove that the powder has the characteristics of good curative effects and higher safety when being used for treating senile vaginitis and is worth clinical application and popularization.
Description
Technical field
The present invention relates to the field of Chinese medicines, be specifically related to a kind of powder preparation method for the treatment of senile vaginitis.
Background technology
Senile vaginitis is common in postclimacteric elderly woman, and because of ovarian failure, estrogen level reduces, vaginal wall atrophy, mucosa is thinning, and in epithelial cell, glycogen content reduces, intravaginal Ph value rises, and local resistance reduces, and pathogenic bacterium are easily invaded breeding and cause and inflammation.Cardinal symptom is that vaginal secretions increases and pruritus vulvae, burning sensation.Inspection is shown in that vagina is senile change, epithelial atrophy, and pleat disappears, and epithelium flattens sliding, poor.Vaginal mucosa is congested, has little petechia, sometimes sees shallow table ulcer.
Senile vaginitis Therapeutic Principle is the growth and breeding increasing vagina resistance and anti-bacteria.Current western medical treatment mostly is supplementary a small amount of estrogen, vaginal mucosa can be made to thicken, build up resistance.But estrogenic unreasonable use easily causes carcinoma of endometrium and breast carcinoma, so there is dispute in this kind of therapeutic scheme always.Bacteria growing inhibiting is then for put into antibiotic powder in intravaginal, but life-time service can cause local flora to be lacked of proper care, and causes larger puzzlement.
And the colpitic suppository of Chinese traditional treatment, outer lotion are many, but be mostly for Women of Childbearing Age, many containing the medicine except noxious dampness such as Radix Sophorae Flavescentis, Fructus Cnidii, the Fructus Kochiae, Rhizoma Smilacis Glabrae in prescription, and the cause of senile vaginitis mainly mucosa is thinning causes, the medicine external of above dispelling the damp pathogen with drugs of bitter in taste and cold in nature, then irritates nucous membrane more, causes aggravation.
Summary of the invention
Technical assignment of the present invention is for above the deficiencies in the prior art, provides a kind of curative effect certainly and the powder of the little treatment senile vaginitis of side effect.
The technical scheme that the present invention solves its technical problem is: a kind of powder for the treatment of senile vaginitis, it is characterized in that being prepared from by the crude drug of following weight proportion: Cortex erythrinae 10 ~ 30 parts, Herba Chlorophyti Laxi 6 ~ 12 parts, go back 3 ~ 10 parts, bobbin, Flos Magnoliae Amoenae 6 ~ 12 parts, Herba Taxilli 3 ~ 10 parts of, Radix Apioris Fortunei 6 ~ 12 parts, Fructus Hordei Germinatus (parched to brown) 6 ~ 12 parts, Massa Medicata Fermentata (parched to brown) 6 ~ 12 parts, Radix Ephedrae 6 ~ 12 parts, Folium Dalbergiae Mimosoidis 1 ~ 5 part, gumshiraz 3 ~ 10 parts, Ramulus Cinnamomi 10 ~ 25 parts.
Chinese medicine of the present invention can be prepared from by following method:
(1) by Cortex erythrinae, Radix Apioris Fortunei, Radix Ephedrae coarse powder distilling under reduced pressure extraction volatile oil respectively, and mixing for standby use after collecting, medicinal residues mixing for standby use;
(2) will go back bobbin decompression decoction 2 times, each 30min, collecting decoction, filters after leaving standstill, obtains filtrate for subsequent use;
(3) gained medicinal residues in Herba Chlorophyti Laxi, Flos Magnoliae Amoenae, Herba Taxilli, Fructus Hordei Germinatus (parched to brown), Massa Medicata Fermentata (parched to brown), Folium Dalbergiae Mimosoidis, gumshiraz, Ramulus Cinnamomi and step 1 are added 10 times of water yields, decoct with water 2 times, each 1 hour, collecting decoction, filter after leaving standstill, obtain filtrate for subsequent use;
(4) step 2 gained filtrate and step 3 gained filtrate are merged, concentrating under reduced pressure becomes dry extract, and drying and crushing obtains dry extract;
(5) spray in step 4 gained dry extract by gained volatile oil in step 1, mixing, cross 100 mesh sieves, subpackage forms.
The pressure of the distilling under reduced pressure in above-mentioned steps (1) is 0.1Mpa.
The pressure that decompression in above-mentioned steps (2) decocts is 0.4Mpa.
The pressure of the concentrating under reduced pressure in above-mentioned steps (4) is 0.4Mpa.
Wherein said: Cortex erythrinae is bark or the root bark of pulse family Erythrinae Arborescentis Erythrina indica Lam..Nature and flavor are bitter, flat.Return liver, kidney channel.Merit can wind-damp dispelling, channels sootheing and network vessel quickening.Wind-damp dispelling, the meridian dredging, parasite killing.
Herba Chlorophyti Laxi is herb or the root of feverfew Prenanthes henryi Dunn Prenanthes henryi Dunn.Bitter in the mouth; Cold in nature.Merit can heat-clearing and toxic substances removing; Dissipating blood stasis stops blooding.
Also bobbin is the fruit of orchid Rhizoma Gastrodiae Gastrodia elata Bl..Sweet in the mouth; Cold in nature.Merit can tonify deficiency subduing the wind syndrome.Main dizzy; Pupil; Wind syndrome of head is had a headache; Weak breath consumption of essence; Early whitening of beard and hair.
Flos Magnoliae Amoenae, is Magnoliaceae head Drymotaenium miyoshianum (Mak.) Mak. Magnolia amoena Cheng, is used as medicine with alabastrum.Nature and flavor are bitter, cold.Merit can diuresis, detumescence, nourishing the lung to arrest cough.
Herba Taxilli, for Herba Taxilli is the dry stem and branch with leaf of Loranthaceae plant Herba Taxilli Taxillus chinensis (DC.) Danser.Nature and flavor bitter, sweet, flat.Return liver, kidney channel.Merit can invigorating the liver and kidney, bone and muscle strengthening, wind-damp dispelling, antiabortive unit.
Radix Apioris Fortunei, is pulse family Radix Apioris Fortunei platymiscium Radix Apioris Fortunei Apios fortunei Maxim., is used as medicine with tuber, leaf and seed.Sweet, the micro-hardship of nature and flavor, flat.Merit can heat-clearing and toxic substances removing, preventing phlegm from forming and stopping coughing.
Fructus Hordei Germinatus (parched to brown), for the mature fruit of grass Fructus Hordei Vulgaris Hordeum vulgare L. is through drying of germinateing, fries to burnt brown according to frying method, cooling, sieve dedust bits.Nature and flavor are sweet, flat.Return spleen, stomach warp.Merit can promote qi circulation digestion promoting, and spleen benefiting and stimulating the appetite, moves back newborn relieving distension.
Massa Medicata Fermentata (parched to brown), for the medicines such as Herba polygoni hydropiperis, Herba Artemisiae Annuae, Semen Armeniacae Amarum add flour or wheat bran mixed after, through the herbal leaven of fermentation, fry to burnt brown according to frying method.Nature and flavor sweet, acrid, warm.Enter spleen, stomach warp.Merit can invigorating the spleen and regulating the stomach, helps digestion in adjusting.
Radix Ephedrae is the dry root and rhizome of Ephedraceae plant plait Herba Ephedrae Ephedra sinica Stapf or epheday intermedia Ephedra intermedia Schrenk et C. A. Mey..Nature and flavor are sweet, flat.GUIXIN, lung meridian.Merit can hidroschesis.
Folium Dalbergiae Mimosoidis is the leaf of leguminous plant trunk rattan Dalbergia mimosoides Franch.GUIXIN; Spleen channel.Merit can heat-clearing and toxic substances removing.
Gumshiraz is rosaceous plant Fructus Persicae Prunus persica (L.) Batsch, the resin that trunk flows out.Nature and flavor are bitter, flat.Merit can be invigorated blood circulation, and QI invigorating is quenched the thirst.
Ramulus Cinnamomi is the dry twig of canella Cortex Cinnamomi Cinnamomum cassia Presl.Nature and flavor acrid, sweet, warm.GUIXIN, lung, urinary bladder channel.Merit can diaphoresis expelling pathogenic factors from muscles, promoting the flow of QI-blood by warming the meridian, supporing yang activating QI, the flat gas that spins.
Composition principle: senile vaginitis is common in postclimacteric elderly woman, because of ovarian failure, the a lot of level of estrogen reduces, vaginal wall atrophy, mucosa is thinning, and in epithelial cell, glycogen content reduces, and intravaginal Ph value rises, local resistance reduces, and pathogenic bacterium are easily invaded breeding and cause and inflammation.Cardinal symptom is that vaginal secretions increases and pruritus vulvae, burning sensation.The colpitic suppository of current Chinese traditional treatment, outer lotion are many, but be mostly for Women of Childbearing Age, many containing the medicine except noxious dampness such as Radix Sophorae Flavescentis, Fructus Cnidii, the Fructus Kochiae, Rhizoma Smilacis Glabrae in prescription, and the cause of senile vaginitis mainly mucosa is thinning causes, the medicine external of above dispelling the damp pathogen with drugs of bitter in taste and cold in nature, then irritates nucous membrane more, causes aggravation.The object of the invention is to avoid using dispelling the damp pathogen with drugs of bitter in taste and cold in nature medicine, and reduce from estrogen level, vaginal wall atrophy, mucosa this pathological change angle thinning is started with, and reaches the object of " treatment of disease must aim at its pathogenesis ".
Compared with prior art, the present invention has following characteristics:
1, prescription is unique, avoids using dispelling the damp pathogen with drugs of bitter in taste and cold in nature antipruritic agent: get Cortex erythrinae in side, go back bobbin for monarch, the Cortex erythrinae dosage recorded in " China's book on Chinese herbal medicine " is: " for oral administration: to decoct soup, 6-12g "; Inventor to test in proof heavy dose of Cortex erythrinae (10 ~ 30g) and can recover by specific promotion vaginal wall mucosa, and goes back bobbin and have similar plants estrogen action, but this act as two-ways regulation, can not produce the low differentiation of estrogen excessive stimulation reproductive system cell;
2, characteristic of the present invention is also balance and restriction: record Cortex erythrinae in 1. " must joining book on Chinese herbal medicine ": " insufficiency of blood heated person forbid ", but gerontal patient's resembling often with deficiency of YIN-blood, and now use Cortex erythrinae, then have and fear its hematozemia and cause yin asthenia generating intrinsic heat to occur; Therefore add Herba Chlorophyti Laxi and go back bobbin, also bobbin merit can train base by tonify deficiency, and can prevent Cortex erythrinae from consuming cloudy blood and liver-wind stirring up internally, and Herba Chlorophyti Laxi bitter in the mouth is cold in nature, utilize on the one hand it coldly to prevent heated, its merit can dissipating blood stasis hemostasis on the other hand, has out entire merit in blood system, prevent Cortex erythrinae to wander away dynamic blood, also can not affect Cortex erythrinae works orderly effect simultaneously; 2. in we, the use of Ramulus Cinnamomi is: a promoting the flow of QI-blood by warming the meridian, supporing yang activating QI, two Yin Yang balancings, to balance the bitter cold of our invasion by pathogenic cold medicine of a cold nature thing; In prescription of the present invention, the application characteristic of Ramulus Cinnamomi is: measure larger (consumption in " Chinese Pharmacopoeia " is 3 ~ 9g), so too disperse for preventing, gets again Radix Ephedrae convergence assistant system;
3, supplementary drug thing is fewer but better: get Flos Magnoliae Amoenae assistant in side and help Herba Chlorophyti Laxi, heat conduction is descending; Radix Apioris Fortunei heat-clearing and toxic substances removing; Herba Taxilli assistant helps goes back bobbin vital base and primordial QI consolidating; Gumshiraz is invigorated blood circulation, and contributes to drag residence in mucomembranous surface, penetration enhancement;
4, inventor's clinical research finds, solid protection gastric qi contributes to the senile vaginitis course of disease and controls and recover, so select Fructus Hordei Germinatus (parched to brown), Massa Medicata Fermentata (parched to brown) spleen benefiting and stimulating the appetite;
5, Folium Dalbergiae Mimosoidis is supplementary drug thing, record in " China book on Chinese herbal medicine " consumption be: " for oral administration: to decoct soup, 9 ~ 15g ", the present inventor's experimental study finds, gets low dose of Folium Dalbergiae Mimosoidis decocting liquid and can improve in vitro vaginal mucosa cytoactive;
6, the homogeneous medicine multiple-effect of institute's thing of getting it filled in side, contributes to reducing medicament categories and consumption, does not increase local excitation;
7, medicine material consumption of the present invention is groped to sum up to draw through inventor in a large number, and each raw material dosage is for all to have good curative effect in following weight parts scope;
8, the fruit that bobbin is orchid Rhizoma Gastrodiae is gone back, compared with Rhizoma Gastrodiae, going back the Esterified Enzyme isozyme (esterase isoenzyme) that bobbin contains, may be that it plays the key of phytoestrogen effect, and inventor's experiment draws, it is higher that decompression goes back bobbin Esterified Enzyme isozyme content after decocting.
Detailed description of the invention
Below in conjunction with practical situation, the specific embodiment of the present invention is elaborated.
Embodiment 1, crude drug weight proportion: Cortex erythrinae 20g, Herba Chlorophyti Laxi 10g, go back bobbin 6g, Flos Magnoliae Amoenae 10g, Herba Taxilli 6g, Radix Apioris Fortunei 10g, Fructus Hordei Germinatus (parched to brown) 10g, Massa Medicata Fermentata (parched to brown) 10g, Radix Ephedrae 10g, Folium Dalbergiae Mimosoidis 2g, gumshiraz 6g, Ramulus Cinnamomi 20g.
The preparation method of embodiment 1 is: by Cortex erythrinae, Herba Chlorophyti Laxi, go back bobbin, Flos Magnoliae Amoenae, Herba Taxilli, Radix Apioris Fortunei, Fructus Hordei Germinatus (parched to brown), Massa Medicata Fermentata (parched to brown), Radix Ephedrae, Folium Dalbergiae Mimosoidis, gumshiraz, the decoction of Ramulus Cinnamomi mixing and water adding, filtrate is got after 30 minutes, medicinal residues add water continue decoction get filtrate after 20 minutes, twice filtrate merges washout, once a day.
Embodiment 2, crude drug weight proportion: Cortex erythrinae 10 parts, Herba Chlorophyti Laxi 6 parts, go back 3 parts, bobbin, Flos Magnoliae Amoenae 6 parts, Herba Taxilli 3 parts of, Radix Apioris Fortunei 6 parts, Fructus Hordei Germinatus (parched to brown) 6 parts, Massa Medicata Fermentata (parched to brown) 6 parts, Radix Ephedrae 6 parts, Folium Dalbergiae Mimosoidis 1 part, gumshiraz 3 parts, Ramulus Cinnamomi 10 parts.
Embodiment 3, crude drug weight proportion: Cortex erythrinae 20 parts, Herba Chlorophyti Laxi 10 parts, go back 6 parts, bobbin, Flos Magnoliae Amoenae 10 parts, Herba Taxilli 6 parts of, Radix Apioris Fortunei 10 parts, Fructus Hordei Germinatus (parched to brown) 10 parts, Massa Medicata Fermentata (parched to brown) 10 parts, Radix Ephedrae 10 parts, Folium Dalbergiae Mimosoidis 2 parts, gumshiraz 6 parts, Ramulus Cinnamomi 20 parts.
Embodiment 4, crude drug weight proportion: Cortex erythrinae 30 parts, Herba Chlorophyti Laxi 12 parts, go back 10 parts, bobbin, Flos Magnoliae Amoenae 12 parts, Herba Taxilli 10 parts of, Radix Apioris Fortunei 12 parts, Fructus Hordei Germinatus (parched to brown) 12 parts, Massa Medicata Fermentata (parched to brown) 12 parts, Radix Ephedrae 12 parts, Folium Dalbergiae Mimosoidis 5 parts, gumshiraz 10 parts, Ramulus Cinnamomi 25 parts.
The Chinese medicine of embodiment 2 ~ 4 can be prepared from by following method:
(1) by Cortex erythrinae, Radix Apioris Fortunei, Radix Ephedrae coarse powder distilling under reduced pressure extraction volatile oil respectively, and mixing for standby use after collecting, medicinal residues mixing for standby use;
(2) will go back bobbin decompression decoction 2 times, each 30min, collecting decoction, filters after leaving standstill, obtains filtrate for subsequent use;
(3) gained medicinal residues in Herba Chlorophyti Laxi, Flos Magnoliae Amoenae, Herba Taxilli, Fructus Hordei Germinatus (parched to brown), Massa Medicata Fermentata (parched to brown), Folium Dalbergiae Mimosoidis, gumshiraz, Ramulus Cinnamomi and step 1 are added 10 times of water yields, decoct with water 2 times, each 1 hour, collecting decoction, filter after leaving standstill, obtain filtrate for subsequent use;
(4) step 2 gained filtrate and step 3 gained filtrate are merged, concentrating under reduced pressure becomes dry extract, and drying and crushing obtains dry extract;
(5) spray in step 4 gained dry extract by gained volatile oil in step 1, mixing, cross 100 mesh sieves, subpackage forms.
In prioritization scheme, the pressure of the distilling under reduced pressure in described step (1) is 0.1Mpa; The pressure that decompression in described step (2) decocts is 0.4Mpa; The pressure of the concentrating under reduced pressure in described step (4) is 0.4Mpa.
The efficient combination of said medicine, coordinates mutually, effectively reach the object for the treatment of senile vaginitis, and side effect is less.The above results is clinical data sufficient proof, and interrelated data is as follows.
1 object and method.
1.1 object.
1 data and method.
1.1.1 case selection: in March, 2011 ~ 2013 are diagnosed as senile vaginitis 248 example year April, at 49 years old ~ 69 years old age, are menopausal women, are limited to 1 year ~ 20 years menopause.
1.1.2 diagnostic criteria: with reference to " obstetrics and gynecology " (the 5th edition), all cases is all clarified a diagnosis according to medical history, gynecologial examination.Symptom is xerosis vulae, pale or the flushing of vaginal mucosa or have little petechia, vaginal health scoring <15 divides, serum follicle stimulating hormone (FSH) >=40IU/L, serum estradiol (E2)≤110pmol/L, abdominal ultrasound examination endometrium thickness <5mm.All patients all carry out vaginal secretions inspection before the treatment and get rid of trichomonal vaginitis, monilial vaginitis, and urine is cultivated negative, without vulvar dystrophy and dermatosis.All cases get rid of hormone-dependent tumor, do not accept hormone medicine treatment over nearly 3 months.
1.1.3 divide into groups: be divided into washout group and powder group, often organize 124 examples.Compare in age, the state of an illness, the course of disease before two groups of patient treatments, no significant difference (P>0.05), has comparability.
1.2 method.
1.2.1 Therapeutic Method: washout group with gained decoct washout in the embodiment of the present invention 1,1 time/d.Powder group is blown deposited with gained powder pudendum and intravaginal in the embodiment of the present invention 4,1 time/d.It within 14 days, is a course for the treatment of.
1.2.2 observation index: conventional inquiry medical history before and after medication, and according to vaginal health point system (VHS) scoring, determine that symptom improves situation.
1.2.3 criterion of therapeutical effect: with reference to " obstetrics and gynecology ", recovery from illness: clinical symptoms, sign disappear; Effective: clinical symptoms, sign turn for the better by and large; Effective: clinical symptoms, sign alleviate; Invalid: clinical symptoms, sign are unchanged.
1.2.4 statistical analysis: SPSS 13.0 carries out statistical analysis.Vaginal health scoring single index adopts nonparametric statistics.Measurement data t checks, enumeration data χ
2inspection.
2 results.
2.1 vaginal symptoms improve situations: all case vagina drying after medication 5d, dyspareunia symptom all start the improvement obtained in various degree.Gynecologial examination vaginal wall elasticity increases, and fold is deepened, and pale, the flushing in surface and bleeding are clearly better.According to vaginal health standards of grading, vaginal health scoring is the summation of elasticity, wettability, pH, mucosa, secretions 5 project score values.Before washout group patient medication, scoring is 8.52 ± 1.32, and average of marking after medication 14d is 13.23 ± 1.63.Before powder group patient medication, scoring is 9.14 ± 2.02, and average of marking after medication 14d is 17.72 ± 2.62.Compare before and after medication, after two groups of patient treatments, vaginal health scoring is all obviously increased (P<0.05).
2.2 liang of group Comprehensive Clinical comparitive study: the cure rate of washout group, obvious effective rate, effective percentage, inefficiency are respectively 57.26%, 33.87%, 8.87%, 0%; The cure rate of powder group, obvious effective rate, effective percentage, inefficiency are respectively 71.77%, 16.94%, 11.29%, 0%.Two groups are compared, and the cure rate of powder group is apparently higher than washout group (χ
2=4.77, P<0.05).
2.3 adverse reaction rates: two groups of patients all do not occur obvious adverse reaction.
2.4 relapse rates: in 3 months, washout group has 3.23%(4/124) case appearance recurrence, powder group has 0.81(1/124) case appearance recurrence.
3. conclusion.
This result of study shows, and washout group of the present invention and powder group treatment senile vaginitis total effective rate are 100%, and the cure rate of powder group is higher than washout group.Have the advantage that untoward reaction is comparatively light, safety is higher.And relapse rate is low in 3 months.
Claims (4)
1. treat the preparation method of senile vaginitis powder for one kind, it is characterized in that, crude drug is: Cortex erythrinae 10 ~ 30 parts, Herba Chlorophyti Laxi 6 ~ 12 parts, go back 3 ~ 10 parts, bobbin, Flos Magnoliae Amoenae 6 ~ 12 parts, Herba Taxilli 3 ~ 10 parts of, Radix Apioris Fortunei 6 ~ 12 parts, Fructus Hordei Germinatus (parched to brown) 6 ~ 12 parts, Massa Medicata Fermentata (parched to brown) 6 ~ 12 parts, Radix Ephedrae 6 ~ 12 parts, Folium Dalbergiae Mimosoidis 1 ~ 5 part, gumshiraz 3 ~ 10 parts, Ramulus Cinnamomi 10 ~ 25 parts; Preparation is made up of following steps:
(1) by Cortex erythrinae, Radix Apioris Fortunei, Radix Ephedrae coarse powder distilling under reduced pressure extraction volatile oil respectively, and mixing for standby use after collecting, medicinal residues mixing for standby use;
(2) will go back bobbin decompression decoction 2 times, each 30min, collecting decoction, filters after leaving standstill, obtains filtrate for subsequent use;
(3) gained medicinal residues in Herba Chlorophyti Laxi, Flos Magnoliae Amoenae, Herba Taxilli, Fructus Hordei Germinatus (parched to brown), Massa Medicata Fermentata (parched to brown), Folium Dalbergiae Mimosoidis, gumshiraz, Ramulus Cinnamomi and step 1 are added 10 times of water yields, decoct with water 2 times, each 1 hour, collecting decoction, filter after leaving standstill, obtain filtrate for subsequent use;
(4) step 2 gained filtrate and step 3 gained filtrate are merged, concentrating under reduced pressure becomes dry extract, and drying and crushing obtains dry extract;
(5) spray in step 4 gained dry extract by gained volatile oil in step 1, mixing, cross 100 mesh sieves, subpackage forms.
2. a kind of preparation method for the treatment of senile vaginitis powder according to claim 1, is characterized in that: the pressure of the distilling under reduced pressure in described step (1) is 0.1Mpa.
3. a kind of preparation method for the treatment of senile vaginitis powder according to claim 1, is characterized in that: the pressure that the decompression in described step (2) decocts is 0.4Mpa.
4. a kind of preparation method for the treatment of senile vaginitis powder according to claim 1, is characterized in that: the pressure of the concentrating under reduced pressure in described step (4) is 0.4Mpa.
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310268846.9A CN103330867B (en) | 2013-07-01 | 2013-07-01 | Preparation method of powder for treating senile vaginitis |
| CN201510104364.9A CN104758733A (en) | 2013-07-01 | 2013-07-01 | External lotion for treating senile vaginitis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310268846.9A CN103330867B (en) | 2013-07-01 | 2013-07-01 | Preparation method of powder for treating senile vaginitis |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510104364.9A Division CN104758733A (en) | 2013-07-01 | 2013-07-01 | External lotion for treating senile vaginitis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103330867A CN103330867A (en) | 2013-10-02 |
| CN103330867B true CN103330867B (en) | 2015-03-04 |
Family
ID=49239117
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310268846.9A Expired - Fee Related CN103330867B (en) | 2013-07-01 | 2013-07-01 | Preparation method of powder for treating senile vaginitis |
| CN201510104364.9A Pending CN104758733A (en) | 2013-07-01 | 2013-07-01 | External lotion for treating senile vaginitis |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510104364.9A Pending CN104758733A (en) | 2013-07-01 | 2013-07-01 | External lotion for treating senile vaginitis |
Country Status (1)
| Country | Link |
|---|---|
| CN (2) | CN103330867B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103316258B (en) * | 2013-07-01 | 2015-06-03 | 青岛市肿瘤医院 | Medicine composition for treating infantile vaginitis |
| CN103316269A (en) * | 2013-07-01 | 2013-09-25 | 付海霞 | Medicine composition for treating primary enuresis |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100739456B1 (en) * | 2005-07-14 | 2007-07-19 | 인하대학교 산학협력단 | Agent for the prevention and treatment of vaginitis containing Artemisia mongolica fishcher extract |
| CN101040941A (en) * | 2007-04-24 | 2007-09-26 | 株洲桦强科技发展有限公司 | Chinese medicine composition for treating skin disease |
| CN101167894B (en) * | 2007-11-09 | 2011-02-16 | 北京中科雍和医药技术有限公司 | Traditional Chinese medicinal washing lotion for treating dermatitis, vulvitis and vaginitis |
| CN101455768A (en) * | 2007-12-12 | 2009-06-17 | 天津市中宝制药有限公司 | Traditional Chinese medicine combination for treating colpitis |
| CN102145064B (en) * | 2011-04-18 | 2012-09-26 | 李佃场 | Traditional Chinese medicine composition for treating senile vaginitis and preparation method thereof |
-
2013
- 2013-07-01 CN CN201310268846.9A patent/CN103330867B/en not_active Expired - Fee Related
- 2013-07-01 CN CN201510104364.9A patent/CN104758733A/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN104758733A (en) | 2015-07-08 |
| CN103330867A (en) | 2013-10-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103520572A (en) | Traditional Chinese composition used for treating atopic dermatitis as well as preparation method of composition | |
| CN103341092B (en) | Preparation method of powder for treating atrophic vaginitis | |
| CN101711848A (en) | Chinese medicinal composition capable of adjunctively treating tumour | |
| CN103285284B (en) | Medical composition for treating senile vaginitis | |
| CN103301353B (en) | Pharmaceutical composition for treating atrophic vaginitis | |
| CN103356932B (en) | A kind of pharmaceutical composition for the treatment of vulva squamous epithelial hyperplasia | |
| CN103330867B (en) | Preparation method of powder for treating senile vaginitis | |
| CN101194998B (en) | Chinese medicine for treating diabetes | |
| CN112717113B (en) | Traditional Chinese medicine composition for treating allergic rhinitis and paste formula and application thereof | |
| CN103301373B (en) | Pharmaceutical composition for treating postpartum perineal mucosal lesions | |
| CN103191399A (en) | Traditional Chinese medicine composition for treating bronchial asthma in acute-outbreak period | |
| CN103330896B (en) | Preparation method of powder for treating postpartum nonspecific vaginitis | |
| CN102940716A (en) | Traditional Chinese medicine for treatment of uterine prolapse | |
| CN103285300B (en) | Medicinal composition for treating stress incontinence | |
| CN103301374B (en) | Pharmaceutical composition for treating postpartum non-specificity vaginitis | |
| CN103341094B (en) | Preparation method of powder for treating vulva squamous epithelial cell hyperplasia | |
| CN103316270B (en) | Preparation method of powder of medicine for treating postnatal perineum mucosal lesion | |
| CN104887950A (en) | Mastitis treatment traditional Chinese medicine compound | |
| CN105250968A (en) | Traditional Chinese medicine preparation for treating asthma | |
| CN103301354B (en) | Preparation method of powder for treating infantile vaginitis | |
| CN103316258B (en) | Medicine composition for treating infantile vaginitis | |
| CN105125964A (en) | Traditional Chinese medicine preparation for treating pelvic peritonitis and preparation method thereof | |
| CN105727237A (en) | Folium artemisiae argyi-containing pharmaceutical composition for treating amenorrhea | |
| CN104225311A (en) | Neurasthenia heart and spleen tonifying medicament and preparation method | |
| CN103285301B (en) | Method for preparing umbilicus dressing agent for treating stress incontinence |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150304 Termination date: 20150701 |
|
| EXPY | Termination of patent right or utility model |